U.S. Markets closed
  • S&P 500

    4,221.86
    -1.84 (-0.04%)
     
  • Dow 30

    33,823.45
    -210.22 (-0.62%)
     
  • Nasdaq

    14,161.35
    +121.67 (+0.87%)
     
  • Russell 2000

    2,287.46
    -27.23 (-1.18%)
     
  • Crude Oil

    71.06
    -1.09 (-1.51%)
     
  • Gold

    1,774.30
    -87.10 (-4.68%)
     
  • Silver

    25.95
    -1.86 (-6.69%)
     
  • EUR/USD

    1.1913
    -0.0087 (-0.7267%)
     
  • 10-Yr Bond

    1.5110
    -0.0580 (-3.70%)
     
  • Vix

    17.75
    -0.40 (-2.20%)
     
  • GBP/USD

    1.3923
    -0.0064 (-0.4553%)
     
  • USD/JPY

    110.2500
    -0.3630 (-0.3282%)
     
  • BTC-USD

    37,701.58
    -892.80 (-2.31%)
     
  • CMC Crypto 200

    937.28
    -32.59 (-3.36%)
     
  • FTSE 100

    7,153.43
    -31.52 (-0.44%)
     
  • Nikkei 225

    29,018.33
    -272.68 (-0.93%)
     

This Bold Statement by the Vertex CEO Means a New Blockbuster May be Here Soon

·4 min read
This Bold Statement by the Vertex CEO Means a New Blockbuster May be Here Soon
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

Vertex Pharmaceuticals (NASDAQ: VRTX) is the leader in cystic fibrosis (CF) treatment -- and it expects to hold that title until at least the late 2030s. The biotech company may be about to prove that, yes, it can. Vertex CEO Reshma Kewalramani made a statement about one of the company's most innovative, exciting programs during the recent earnings call.